At week 26, LDL-C was reduced by 19.0% (-36.0% to -1.9%, p=.029) in the tirzepatide 15 mg group compared to placebo while it was reduced by 17.8% (-33.7% to -2.0%, p= 0.028) in the dulaglutide 1.5 mg group compared to placebo though differences between the 2 medications were not seen [60]
To calculate exact volumes, use our free Peptide Reconstitution Calculator
Essentially, these medications function best as part of a comprehensive weight management plan, rather than a standalone solution
Here are some additional strategies to consider
OTC generic comparisons are based on factors such as active ingredient, strength, dosage form, package size, labeling, availability, and practical use case
Our clinical experience extends to helping patients understand the lesser-known GLP-1 benefits that may improve their health outcomes